ARP Rheumatology succeeds Acta Reumatológica Portuguesa, originally founded in 1973 as the official journal of the Portuguese Society of Rheumatology.
It is a scientific double-blinded peer-reviewed and open-access journal devoted to progress in the research, diagnosis and treatment of rheumatic and musculoskeletal diseases. Both basic research and clinical papers may be submitted.
The journal aims at serving the interest of both practising clinicians and research workers. Editorials, short communications and review articles covering recent developments are included. Controversial techniques and issues on health policy are frequently discussed and serve as tools for encouraging debate. It also concerns about guidelines and clinical protocols related to the practice of rheumatology.
ARP Rheumatology is indexed on PubMed/ Medline, has no publication fees and all the articles are available online with free access.
The journal subscribes the requirements for the acceptance of manuscripts in biomedical journals proposed by the International Committee of Medical Journal Editors, published initially in N Engl J Med 1991; 324: 42428, available in www.ICMJE.org.
ARP Rheumatology adheres to the highest standards concerning its editorial policies on publication ethics and scientific misconduct, consent and peer review criteria. The journal follows guidance produced by the Council of Science Editors. Authors are required to submit a statement that their study obtained ethics approval (or a statement that it was not required and why) and that participants gave informed consent. Our Editors will consider whether the work is ethically acceptable as determined by the Declaration of Helsinki. In addition to this, an article that contains personal medical information about an identifiable living individual requires patients' explicit consent before we will publish it.
Personal and Institutional subscribers may access the journal online via: www.arprheumatology.com.